Transcatheter Aortic Valves At The Five-Year Mark
Executive Summary
Published data on transcatheter aortic valve implantation has reached the five-year mark and the outcomes suggest these devices may be as durable as many surgical valves, which is good news for this rapidly-growing market.
You may also be interested in...
Transcatheter Valves At The Tipping Point
Although Edwards is the pioneer and market leader in TAVR, there is no shortage of competitors – in both the aortic and mitral valve segments – developing next-generation devices who would be happy with a fraction of this potential multibillion-dollar opportunity.
CMS To Pay Co-Surgeons For Transcatheter Valve Procedures, But At Lower Value Than Sought By Physicians
Surgeons and cardiologists who perform transcatheter aortic valve replacement procedures will be paid for the total amount of their work in 2013, but CMS’ adoption of a lower relative value unit for TAVR will result in a lower payment amount.
Transcatheter Valve Procedures Expected, Spurring Growth In Hybrid Operating Rooms
Infrastructure requirements for hospitals looking to expand their offerings to TAVR include a boatload of medical equipment. ECRI Institute discussed hospital considerations for offering transcatheter aortic valve implantation services in a recent webinar.